159 related articles for article (PubMed ID: 26598634)
1. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
Fox H; Hunter F
Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
[TBL] [Abstract][Full Text] [Related]
2. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
Hilton L; Reuben A
Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
[TBL] [Abstract][Full Text] [Related]
3. Topical tranexamic acid for spontaneous epistaxis.
Santander MJ; Rosenbaum A; Winter M
Medwave; 2018 Dec; 18(8):e7372. PubMed ID: 30550535
[TBL] [Abstract][Full Text] [Related]
4. BET 1: Does inhaled tranexamic acid reduce morbidity in adults with haemoptysis?
Mervau J; Jason S; Jones JS
Emerg Med J; 2020 Jan; 37(1):45-46. PubMed ID: 31848266
[TBL] [Abstract][Full Text] [Related]
5. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis.
Heymer J; Schilling T; Räpple D
Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357
[No Abstract] [Full Text] [Related]
6. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sabbà C; Gallitelli M; Palasciano G
N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
[No Abstract] [Full Text] [Related]
7. BET 1: Tranexamic acid in epistaxis: who bloody nose?
Penrose N; May G
Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid in hereditary hemorrhagic telangiectasia.
Lozano M
N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
[No Abstract] [Full Text] [Related]
9. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
Klepfish A; Berrebi A; Schattner A
Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
[No Abstract] [Full Text] [Related]
10. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
Hassen GW; Clemons P; Kaplun M; Kalantari H
Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
[TBL] [Abstract][Full Text] [Related]
11. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
Bridwell RE; April MD; Long B
Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
[No Abstract] [Full Text] [Related]
12. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
[TBL] [Abstract][Full Text] [Related]
13. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
Logan JK; Pantle H
Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
[TBL] [Abstract][Full Text] [Related]
14. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: tranexamic acid in life-threatening haematuria.
Emerg Med J; 2015 Feb; 32(2):168-9. PubMed ID: 25605262
[TBL] [Abstract][Full Text] [Related]
15. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department.
Birmingham AR; Mah ND; Ran R; Hansen M
Am J Emerg Med; 2018 Jul; 36(7):1242-1245. PubMed ID: 29602670
[TBL] [Abstract][Full Text] [Related]
16. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
Eberle ML; Schechter-Perkins EM; Altawil Z
Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic acid in epistaxis: a systematic review.
Kamhieh Y; Fox H
Clin Otolaryngol; 2016 Dec; 41(6):771-776. PubMed ID: 26946067
[TBL] [Abstract][Full Text] [Related]
18. BET 1: Intravenous tranexamic acid for the treatment of post-partum haemorrhage.
Coss C; Singh M; Jones J
Emerg Med J; 2018 Aug; 35(8):523-524. PubMed ID: 30030237
[TBL] [Abstract][Full Text] [Related]
19. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.
Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P
BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866
[TBL] [Abstract][Full Text] [Related]
20. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
